key ebmt guideline updates for the treatment and prophylaxis of gvhd
Published 1 year ago • 103 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:10
key highlights from ebmt 2023
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
1:08
the progress of the ebmt & key ongoing projects
-
0:58
management strategies for acute and chronic gvhd following allosct
-
0:45
key trials in cll and designing a concept for treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:46:07
hematology lecture
-
9:59
dr. kessler addresses questions about your hematology appointment
-
19:06
peripheral blood smear: examination of rbc
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:41
an overview of the latest advances in hematology
-
1:25
key changes in the hct survivorship guidelines
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
4:22
management of acute gvhd
-
1:33
key factors affecting treatment decision making in cll
-
1:14
highlights in quality management from ebmt
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation